HETERO LABS LIMITED

Location

Telangana

Founded

1989-03-10

Risk Signals

280 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about HETERO LABS LIMITED

Live alerts from global media, monitored by Business Radar

Telangana: Six pharma giants to invest Rs 5,260 cr in Pharma City

2024-11-23 (telanganatoday.com)

Telangana: Six pharma giants to invest Rs 5,260 cr in Pharma City

Under the agreements, MSN Laboratory will establish a manufacturing unit along with a Research & Development (R&D) center. Laurus Labs and Aurobindo Pharma will set up formulation units. Gland Pharma has shown interest in opening an R&D center, as well as manufacturing units for injectables and drug substances. Dr. Reddy's Labs plans to establish a unit for injectables and biosimilars. Hetero Labs will set up a plant for finished dose and injectable manufacturing.

Read more
150 Jobs Opening in Hetero Lab Limited

2024-10-22 (sakshi.com)

150 Jobs Opening in Hetero Lab Limited

Hetero Lab Limited is searching for talented individuals to join their team as Production QC Maintenance

Read more
Bringing together creative economy players, Hetero Fest 2024 will be held again in Solo

2024-09-29 (joglosemarnews.com)

Bringing together creative economy players, Hetero Fest 2024 will be held again in Solo

SOLO, JOGLOSEMARNEWS.COM -- Head of the Central Java Province MSME Cooperative Service, Eddy S. Bramiyanto officially opened the Hetero Fest 2024 event at Hetero Space,

Read more
MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19 -

2021-04-27 (economictimes.com)

MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19 -

MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.

Read more
New launches to prop sales recovery as GSK Pharma gets over Zinetac pain

2021-04-10 (business-standard.com)

New launches to prop sales recovery as GSK Pharma gets over Zinetac pain

Near-term gains may be limited given restrictions which will impact anti-infectives portfolio

Read more

Never miss a headline about HETERO LABS LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages